Media

Our latest news and articles

Genetic detection isn’t always clinical truth: why phenotypic AMR testing still matters
Blog

Genetic detection isn’t always clinical truth: why phenotypic AMR testing still matters 

Genes predict resistance, phenotype proves reality. Why phenotypic AMR testing remains essential for confident antibiotic decisions. 

Apr 24 2026
Innovation at scale: Overcoming the challenges of battery manufacturing
Blog

Innovation at scale: Overcoming the challenges of battery manufacturing 

Scaling next‑gen battery materials is a key challenge as innovators struggle to move from lab breakthroughs to reliable, industrial‑scale production. 

Mar 27 2026
UK launches £5 million next-generation cancer diagnostics programme to accelerate early detection and adoption
News

UK launches £5 million next-generation cancer diagnostics programme to accelerate early detection and adoption 

UK launches £5m programme to speed next‑gen cancer diagnostics by uniting industry, clinicians, patients and tech leaders to advance early detection. 

Mar 24 2026
Purification is the bottleneck in oligonucleotide manufacturing. Can it be reinvented from scratch?
Blog

Purification is the bottleneck in oligonucleotide manufacturing. Can it be reinvented from scratch? 

As purification becomes the bottleneck in oligonucleotide manufacturing, how will the industry rethink scalable, cost‑effective production? 

Mar 18 2026
UK HealthTech Industrial Council marks first year accelerating innovation, investment and collaboration across the MedTech sector
News

UK HealthTech Industrial Council marks first year accelerating innovation, investment and collaboration across the MedTech sector 

UK HealthTech Industrial Council drives R&D, manufacturing resilience and innovation across the MedTech sector in its first year. 

Mar 18 2026
CPI and Medicines Discovery Catapult launch project to unlock faster, lower-risk development of next-generation RNA medicines
News

CPI and Medicines Discovery Catapult launch project to unlock faster, lower-risk development of next-generation RNA medicines 

CPI and MDC join forces to overcome a key barrier in developing and scaling next‑generation RNA medicines. 

Mar 17 2026
Can biology destroy PFAS?
Blog

Can biology destroy PFAS? 

Can biology help tackle PFAS? Advances in enzymes, microbes and synthetic biology are opening new possibilities for removing these ​“forever chemicals”. 

Mar 16 2026
From chemistry to component: New NCC and CPI partnership to strengthen UK materials capability
News

From chemistry to component: New NCC and CPI partnership to strengthen UK materials capability 

NCC and CPI partner to boost UK materials innovation and help scale composites and advanced materials from research to commercial use. 

Mar 10 2026
Scaling up a process: the questions that matter most
Blog

Scaling up a process: the questions that matter most 

Discover the key technical and commercial questions that shape successful process scale-up, from market insight to costs, risks and sustainability. 

Mar 09 2026
Next  
1 2 3 Next  

Page 1 of 105

CPI is your innovation partner to make your ideas a reality.